Analytical Bio-Chemistry Laboratories and Accium BioSciences Announce a Partnership to Offer Microdosing and Low Radiation Services

Business Wire, Feb 26, 2007

COLUMBIA, Mo. & SEATTLE -- Analytical Bio-Chemistry Laboratories, Inc. and Accium BioSciences, Inc. announced a collaboration that will streamline the process of preparing for and performing radiolabeled PK/ADME studies for their pharmaceutical and biotechnology clients.

The relationship combines Analytical Bio-Chemistry Laboratories' expertise in synthesizing 14C-labeled molecules with Accium's expertise in Accelerator Mass Spectrometry (AMS) based analytical services to support E-IND, microdosing and low radiation Phase 0 and Phase I services.

"This collaboration will facilitate rapid and more informed decisions relative to a compound's promise early in the development process," said Noel Premkumar, Ph.D., Director Regulatory Strategy at ABC. "It allows each company to focus on its strengths and provides our mutual customers with a conveniently bundled service package." ABC and Accium plan to co-market a package that includes synthesis of 14C-labeled drug substance, dose preparation for 14C-labeled drug, and follow-up AMS services needed to support Phase 0 and micro-radiation Phase I clinical studies.

"Our alliance with Analytical Bio-Chemistry Labs closes the loop for our mutual clients. From synthesis of lightly labeled compounds through regulatory filings to final reports, we provide a seamless path to enable critical go/no-go decisions earlier in drug development process," said Michael Chansler, Vice President of Business Development and Sales for Accium.

About Analytical Bio-Chemistry Laboratories, Inc.

Analytical Bio-Chemistry (ABC) Laboratories, Inc. is a GLP, cGMP compliant drug development partner with expertise in non-routine analytical services and synthesis in support of preclinical, clinical and CMC-related activities. From its inception in 1968, ABC Laboratories has been dedicated to solving scientific problems and providing expert analytical chemistry services to businesses required to meet government health and safety regulations. Our technical expertise in analytical chemistry is backed by rigor in regulatory compliance, continual process improvement and a passion for customer satisfaction.

For additional information, visit http://www.abclabs.com or contact Kristein King at (573) 441-4409.

About Accium BioSciences, Inc.

Accium BioSciences, Inc. is a specialty CRO providing early drug development services to pharmaceutical and biotechnology industry clients. The company operates a full-service Accelerator Mass Spectrometry (AMS) laboratory facility in North America. Services include protocol design, project management, regulatory consulting and ultra-sensitive analytical services to GLP standards. Accium's experts enable Microdosing (Exploratory-IND) studies and low-radiation PK/ADME phase I clinical trials.

For additional information, visit www.acciumbio.com or contact Michael Chansler at (206) 281-3915.